CVS Health Corp (NYSE: CVS) kicked off on Friday, up 1.20% from the previous trading day, before settling in for the closing price of $58.36. Over the past 52 weeks, CVS has traded in a range of $52.77-$83.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 13.36%. While this was happening, its average annual earnings per share was recorded -19.43%. With a float of $1.25 billion, this company’s outstanding shares have now reached $1.29 billion.
Let’s determine the extent of company efficiency that accounts for 300000 employees.
CVS Health Corp (CVS) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of CVS Health Corp is 0.18%, while institutional ownership is 81.62%. The most recent insider transaction that took place on May 02 ’24, was worth 500,294. In this transaction Director of this company bought 9,181 shares at a rate of $54.49, taking the stock ownership to the 9,356 shares. Before that another transaction happened on May 02 ’24, when Company’s Director bought 1,000 for $53.88, making the entire transaction worth $53,879. This insider now owns 21,630 shares in total.
CVS Health Corp (CVS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -19.43% per share during the next fiscal year.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
Take a look at CVS Health Corp’s (CVS) current performance indicators. Last quarter, stock had a quick ratio of 0.61. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.21. Likewise, its price to free cash flow for the trailing twelve months is 9.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.69, a number that is poised to hit 1.76 in the next quarter and is forecasted to reach 7.87 in one year’s time.
Technical Analysis of CVS Health Corp (CVS)
Looking closely at CVS Health Corp (NYSE: CVS), its last 5-days average volume was 11.18 million, which is a drop from its year-to-date volume of 12.1 million. As of the previous 9 days, the stock’s Stochastic %D was 37.86%. Additionally, its Average True Range was 1.60.
During the past 100 days, CVS Health Corp’s (CVS) raw stochastic average was set at 22.48%, which indicates a significant decrease from 37.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 24.24% in the past 14 days, which was lower than the 38.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $60.01, while its 200-day Moving Average is $70.03. However, in the short run, CVS Health Corp’s stock first resistance to watch stands at $59.87. Second resistance stands at $60.69. The third major resistance level sits at $61.39. If the price goes on to break the first support level at $58.36, it is likely to go to the next support level at $57.66. Now, if the price goes above the second support level, the third support stands at $56.84.
CVS Health Corp (NYSE: CVS) Key Stats
The company with the Market Capitalisation of 74.14 billion has total of 1,255,373K Shares Outstanding. Its annual sales at the moment are 357,776 M in contrast with the sum of 8,344 M annual income. Company’s last quarter sales were recorded 88,437 M and last quarter income was 1,113 M.
